Mucolytics in COPD: Like red wine?
More details
Hide details
Editorial Board Pneumon
Corresponding author
Stelios Loukides   

2 Smolika street, 166 73 Athens
Pneumon 2013;26(4):303-306
Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
Hillas G, Nikolakopoulou S, Hussain S, Vassilakopoulos T. Antioxidants and mucolytics in COPD management: when (if ever) and in whom? Curr Drug Targets 2013;14:225-234.
Burgel PR, Martin C. Mucus hypersecretion in COPD: should we only rely on symptoms? Eur Respir Rev 2010;19:94-96.
Culpitt SV, Rogers DF, Fenwick PS, et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 2003;58:942-946.
Decramer M, Janssens W. Mucoactive therapy in COPD. Eur Respir Rev 2010;19:134-140.
Poole P, Black PN, Cates CJ. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012 Aug 15;8:.
Zheng JP, Kang J, Huang SG, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet 2008;371:2013-2018.
Gerrits CM, Herings RM, Leufkens HG, Lammers JW. N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease. Eur Respir J 2003; 21:795-798.
Decramer M, Rutten-van Mölken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC CostUtility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 2005;365:1552-1560.
Demedts M, Behr J, Buhl R, et al; IFIGENIA Study Group.Highdose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-2242.
Tse HN, Raiteri L, Wong KY, et al. High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebocontrolled HIACE study. Chest 2013;144:106-118.
McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365:1567-1575.
Zheng JP, Wen FQ, Bai CX, et al; PANTHEON study committee. High-dose N-acetylcysteine in the prevention of COPD exacerbations: rationale and design of the PANTHEON Study. COPD 2013;10:164-171.
Zheng P, Wen FQ, Bai CX, et al. High-dose N-acetylcysteine in the prevention of COPD exacerbations: Results of the PANTHEON study. ERS 2013 Poster 3394.
Journals System - logo
Scroll to top